Connect with us

International

WHO approves China’s Sinovac Covid jab

AFP/Editor

The World Health Organization on Tuesday approved the Sinovac Covid-19 vaccine for emergency use — the second Chinese jab to receive the WHO’s green light.

The UN health agency signed off on the Beijing-based firm Sinovac’s two-dose vaccine CoronaVac, which is already being deployed in several countries around the world.

“I’m happy to announce that the Sinovac-CoronaVac vaccine has been given WHO emergency use listing after being found to be safe, effective, and quality-assured,” WHO chief Tedros Adhanom Ghebreyesus told a press conference.

“The easy storage requirements of CoronaVac make it very suitable for low-resource settings,” he added.

Advertisement
20260224_estafa_mh_728x90
previous arrow
next arrow

“It’s now crucial to get these life-saving tools to the people that need them quickly.”

The WHO said the emergency use listing (EUL) gives countries, funders, procuring agencies and communities assurance that the vaccine has met international standards.

Last month Sinopharm became the first Chinese vaccine to be approved by the WHO.

The organisation has also given EUL status to vaccines being made by Pfizer/BioNTech, Moderna, Johnson & Johnson, and the AstraZeneca jab being produced in India, South Korea and the EU, which it counts separately.

WHO’s listing paves the way for countries worldwide to approve and import a vaccine for distribution quickly, especially those states without an international-standard regulator of their own.

Advertisement
20260224_estafa_mh_728x90
previous arrow
next arrow

It also opens the door for the jabs to enter the Covax global vaccine-sharing facility, which aims to provide equitable access to doses around the world, particularly in poorer countries.

Currently only AstraZeneca and some Pfizer jabs are flowing through the scheme.

“The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe,” said Mariangela Simao, the WHO’s assistant director general for access to health products.

“We urge manufacturers to participate in the Covax facility, share their know-how and data and contribute to bringing the pandemic under control.”

– Efficacy rate –

“WHO recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks,” the agency said in a statement.

Advertisement
20260224_estafa_mh_728x90
previous arrow
next arrow

“Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51 percent of those vaccinated and prevented severe Covid-19 and hospitalisation in 100 percent of the studied population.”

The Sinovac vaccine contains an inactivated form of coronavirus that cannot cause the disease. It also has a substance that helps strengthen the immune response to the vaccine.

When given the shot, the immune system identifies the inactivated virus as foreign and makes antibodies against it, which will then recognise the active virus and defend the body against it.

Few people aged over 60 took part in the clinical trial of Sinovac’s jab.

However, the WHO said there should be no upper age limit on the vaccine as there is “no reason to believe it has a different safety profile” in older generations.

Advertisement
20260224_estafa_mh_728x90
previous arrow
next arrow

The Sinovac jab is already in use in 22 territories around the world, according to an AFP count.

Apart from China, the countries using Sinovac include Chile, Brazil, Indonesia, Mexico, Thailand and Turkey.

Chen Xu, China’s ambassador in Geneva, said CoronaVac’s EUL status expanded the number of global tools to fight the pandemic.

“China will continue to work with the international community to promote the accessibility and affordability of Covid-19 vaccines especially in (the) developing world,” he said in a tweet.

Advertisement
20260224_estafa_mh_728x90
previous arrow
next arrow
Continue Reading
Advertisement
20260224_estafa_mh_300x250

International

US panel backs Trump-themed coin amid controversy

The United States Department of the Treasury confirmed to AFP that the Commission of Fine Arts approved the design of a new collectible coin featuring Donald Trump, with members of the commission appointed by the current administration.

According to the proposal, the coin will feature an image of Trump standing with clenched fists over a desk on the obverse, while the reverse will display an eagle, a traditional symbol of the United States.

The sale price of the collectible has not yet been disclosed, although the United States Mint typically offers similar items for more than $1,000.

“There is no more iconic portrait for the front of these coins than that of our president Donald Trump,” U.S. Treasurer Brandon Beach said in a statement sent to AFP. He added that two additional coins — a $1 piece and a one-ounce gold coin — are also under consideration.

However, the Citizens Coinage Advisory Committee (CCAC), another body responsible for reviewing new coin proposals, declined to discuss the Trump design in late February.

Advertisement

20260224_estafa_mh_728x90

previous arrow
next arrow

“Only nations governed by kings or dictators place the image of a sitting leader on their currency,” said Donald Scarinciat the time. “No country in the world has minted coins featuring a democratically elected leader during their term in office,” he added.

When contacted by AFP, the Treasury Department did not immediately respond to requests for further comment.

Continue Reading

International

Fed’s Waller warns of rising inflation risks amid Middle East conflict

Christopher Waller, a governor at the Federal Reserve, said Friday that he is increasingly concerned about the inflationary impact of the ongoing conflict involving United States and Israel against Iran, particularly due to the prolonged closure of the Strait of Hormuz.

Waller, who had supported interest rate cuts over the past year amid concerns about the labor market, said he has shifted his stance in recent weeks due to rising inflation risks.

“Since the Strait of Hormuz was closed, it suggests this conflict could be much more prolonged and that oil prices will remain elevated for longer,” Waller said in an interview with CNBC.

“Therefore, this indicates that inflation is a greater concern than I had previously assessed,” he added.

Waller also backed the Federal Reserve’s decision earlier this week to keep interest rates unchanged, signaling a more cautious approach as global geopolitical tensions continue to affect economic outlooks.

Advertisement

20260224_estafa_mh_728x90

previous arrow
next arrow

Continue Reading

International

Brazil offers to mediate Colombia-Ecuador tensions, calls for restraint

The government of Brazil has offered to mediate in the ongoing tensions between Colombia and Ecuador, while calling on both nations to exercise restraint.

In a statement released Wednesday, Brazil’s Ministry of Foreign Affairs urged the parties involved to act with moderation and seek a peaceful resolution to the dispute.

“Brazil encourages all sides to act with moderation in order to find a peaceful solution to the controversy. It stands ready to support dialogue efforts aimed at preserving peace and security in the region,” the statement said.

Brazil also expressed “serious concern” over reports of deaths in the border area between Colombia and Ecuador, noting that the circumstances surrounding the incidents have not yet been clarified.

The diplomatic move comes amid rising tensions between the neighboring countries, increasing regional concern over stability and security along their shared border.

Advertisement

20260224_estafa_mh_728x90

previous arrow
next arrow

Continue Reading

Trending

Central News